about
Neuroplasticity and the next wave of antidepressant strategiesSSRI Antidepressant Medications: Adverse Effects and TolerabilityOn the feasibility of designing new antidepressants.Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms.Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease.Evaluation of polysaccharide-based chiral stationary phases in quality control of (S)-mirtazapine.Severe serotonin syndrome induced by mirtazapine monotherapy.Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude miceEstrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: A possible mechanism for menopausal depression.Chronic methamphetamine self-administration disrupts cortical control of cognition.Superior oblique myokymia: characteristics and treatment options.Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depression: effects of mirtazapine treatment.Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions.
P2860
Q21129480-1D358E6B-F154-4A7D-A2C9-D44872D8C77EQ24682995-ADDA961B-5C5C-40AA-8C2E-5DA04BE9646DQ31116056-E93D158F-B428-4A08-A89B-F47AAB56D1DBQ33185514-C3774BDB-5949-42D5-B9ED-E7FFE461E37FQ33254664-7611F619-362A-412F-8B5B-C67843BB654EQ33826463-03B61B91-8EC3-44AA-A2A8-A5F71394D74AQ33888314-F33CE9D0-DAE8-44CF-A1C9-E3A1CFBD3DBAQ34579618-4125C5BF-A5C7-4CB3-AF41-7F5BDC7AC228Q36031360-4A6142DB-0121-42E9-BF5C-050B233915E0Q36061821-239518DF-F043-4ECA-89EB-C4B2261E24A4Q36759259-3AC39F10-6184-4230-861D-3672B02FCC34Q37316686-1087AB3D-5613-4093-A181-9D9C4F8F58AAQ38763596-CD26EC57-6259-48E3-9506-66269684EAA1Q38906406-312FB060-D805-4B1F-BBB1-365C84EDCF7AQ42781092-69C05426-F491-4146-B410-9FF3D16A6968Q44662313-C187D21E-2861-40FB-A7D4-881FB14C1C20Q46955331-02AD5FDC-C799-4C82-BE97-2956F91330ECQ50919551-25EAC85C-BF12-4546-BC41-1C55B9197F3F
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mirtazapine: a review of its use in major depression.
@ast
Mirtazapine: a review of its use in major depression.
@en
Mirtazapine: a review of its use in major depression.
@en-gb
type
label
Mirtazapine: a review of its use in major depression.
@ast
Mirtazapine: a review of its use in major depression.
@en
Mirtazapine: a review of its use in major depression.
@en-gb
prefLabel
Mirtazapine: a review of its use in major depression.
@ast
Mirtazapine: a review of its use in major depression.
@en
Mirtazapine: a review of its use in major depression.
@en-gb
P1433
P1476
Mirtazapine: a review of its use in major depression.
@en
P2093
P304
P356
10.2165/00003495-199957040-00010
P577
1999-04-01T00:00:00Z
P6179
1041078223